vs

Side-by-side financial comparison of ACACIA RESEARCH CORP (ACTG) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.

Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $50.1M, roughly 1.2× ACACIA RESEARCH CORP). ACACIA RESEARCH CORP runs the higher net margin — 6.8% vs -70.9%, a 77.7% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 2.6%). Over the past eight quarters, ACACIA RESEARCH CORP's revenue compounded faster (43.6% CAGR vs 17.7%).

Acacia Research Corporation is a publicly traded American company based in New York City. It acquires and operates businesses in industries including the technology, energy, and industrial/manufacturing sectors. Acacia has a strategic relationship with Starboard Value, LP, the company's controlling shareholder. The company has been characterized as a patent troll.

Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.

ACTG vs CTKB — Head-to-Head

Bigger by revenue
CTKB
CTKB
1.2× larger
CTKB
$62.1M
$50.1M
ACTG
Growing faster (revenue YoY)
CTKB
CTKB
+5.5% gap
CTKB
8.1%
2.6%
ACTG
Higher net margin
ACTG
ACTG
77.7% more per $
ACTG
6.8%
-70.9%
CTKB
Faster 2-yr revenue CAGR
ACTG
ACTG
Annualised
ACTG
43.6%
17.7%
CTKB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACTG
ACTG
CTKB
CTKB
Revenue
$50.1M
$62.1M
Net Profit
$3.4M
$-44.1M
Gross Margin
12.8%
52.9%
Operating Margin
-26.1%
-9.0%
Net Margin
6.8%
-70.9%
Revenue YoY
2.6%
8.1%
Net Profit YoY
125.5%
-557.1%
EPS (diluted)
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACTG
ACTG
CTKB
CTKB
Q4 25
$50.1M
$62.1M
Q3 25
$59.4M
$52.3M
Q2 25
$51.2M
$45.6M
Q1 25
$124.4M
$41.5M
Q4 24
$48.8M
$57.5M
Q3 24
$23.3M
$51.5M
Q2 24
$25.8M
$46.6M
Q1 24
$24.3M
$44.9M
Net Profit
ACTG
ACTG
CTKB
CTKB
Q4 25
$3.4M
$-44.1M
Q3 25
$-2.7M
$-5.5M
Q2 25
$-3.3M
$-5.6M
Q1 25
$24.3M
$-11.4M
Q4 24
$-13.4M
$9.6M
Q3 24
$-14.0M
$941.0K
Q2 24
$-8.4M
$-10.4M
Q1 24
$-186.0K
$-6.2M
Gross Margin
ACTG
ACTG
CTKB
CTKB
Q4 25
12.8%
52.9%
Q3 25
21.2%
52.7%
Q2 25
12.8%
52.3%
Q1 25
47.4%
48.6%
Q4 24
17.6%
58.5%
Q3 24
10.1%
56.3%
Q2 24
26.2%
54.6%
Q1 24
49.2%
51.3%
Operating Margin
ACTG
ACTG
CTKB
CTKB
Q4 25
-26.1%
-9.0%
Q3 25
-10.8%
-17.6%
Q2 25
-24.2%
-23.3%
Q1 25
30.8%
-36.1%
Q4 24
-32.4%
5.2%
Q3 24
-44.1%
-8.2%
Q2 24
-18.4%
-18.3%
Q1 24
-8.6%
-23.9%
Net Margin
ACTG
ACTG
CTKB
CTKB
Q4 25
6.8%
-70.9%
Q3 25
-4.6%
-10.5%
Q2 25
-6.4%
-12.2%
Q1 25
19.5%
-27.5%
Q4 24
-27.5%
16.8%
Q3 24
-60.0%
1.8%
Q2 24
-32.7%
-22.4%
Q1 24
-0.8%
-13.8%
EPS (diluted)
ACTG
ACTG
CTKB
CTKB
Q4 25
$0.03
Q3 25
$-0.03
Q2 25
$-0.03
Q1 25
$0.25
Q4 24
$-0.14
Q3 24
$-0.14
Q2 24
$-0.08
Q1 24
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACTG
ACTG
CTKB
CTKB
Cash + ST InvestmentsLiquidity on hand
$306.7M
$90.9M
Total DebtLower is stronger
$91.9M
Stockholders' EquityBook value
$543.5M
$341.7M
Total Assets
$771.0M
$461.5M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACTG
ACTG
CTKB
CTKB
Q4 25
$306.7M
$90.9M
Q3 25
$301.8M
$93.3M
Q2 25
$316.7M
$75.5M
Q1 25
$272.0M
$95.3M
Q4 24
$273.9M
$98.7M
Q3 24
$410.9M
$162.3M
Q2 24
$441.9M
$177.9M
Q1 24
$498.4M
$168.8M
Total Debt
ACTG
ACTG
CTKB
CTKB
Q4 25
$91.9M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ACTG
ACTG
CTKB
CTKB
Q4 25
$543.5M
$341.7M
Q3 25
$537.6M
$378.6M
Q2 25
$538.6M
$377.6M
Q1 25
$540.2M
$379.6M
Q4 24
$514.8M
$395.7M
Q3 24
$540.2M
$385.5M
Q2 24
$560.7M
$389.1M
Q1 24
$568.3M
$392.6M
Total Assets
ACTG
ACTG
CTKB
CTKB
Q4 25
$771.0M
$461.5M
Q3 25
$768.9M
$494.9M
Q2 25
$775.5M
$493.3M
Q1 25
$801.6M
$482.6M
Q4 24
$756.4M
$499.5M
Q3 24
$707.6M
$491.2M
Q2 24
$753.6M
$483.7M
Q1 24
$631.7M
$492.1M
Debt / Equity
ACTG
ACTG
CTKB
CTKB
Q4 25
0.17×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACTG
ACTG
CTKB
CTKB
Operating Cash FlowLast quarter
$75.2M
$-771.0K
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-2.9%
Capex IntensityCapex / Revenue
1.6%
Cash ConversionOCF / Net Profit
22.01×
TTM Free Cash FlowTrailing 4 quarters
$-8.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACTG
ACTG
CTKB
CTKB
Q4 25
$75.2M
$-771.0K
Q3 25
$9.5M
$-3.9M
Q2 25
$50.1M
$108.0K
Q1 25
$2.4M
$-125.0K
Q4 24
$50.1M
$2.0M
Q3 24
$-593.0K
$13.2M
Q2 24
$16.1M
$6.2M
Q1 24
$54.8M
$4.0M
Free Cash Flow
ACTG
ACTG
CTKB
CTKB
Q4 25
$-1.8M
Q3 25
$-4.6M
Q2 25
$-1.5M
Q1 25
$335.0K
$-974.0K
Q4 24
$-98.5M
$1.1M
Q3 24
$-2.8M
$12.2M
Q2 24
$-126.7M
$5.2M
Q1 24
$54.6M
$3.4M
FCF Margin
ACTG
ACTG
CTKB
CTKB
Q4 25
-2.9%
Q3 25
-8.7%
Q2 25
-3.2%
Q1 25
0.3%
-2.3%
Q4 24
-201.8%
1.9%
Q3 24
-12.1%
23.7%
Q2 24
-490.5%
11.0%
Q1 24
224.4%
7.6%
Capex Intensity
ACTG
ACTG
CTKB
CTKB
Q4 25
1.6%
Q3 25
1.3%
Q2 25
3.5%
Q1 25
1.7%
2.0%
Q4 24
304.4%
1.6%
Q3 24
9.6%
2.0%
Q2 24
553.0%
2.3%
Q1 24
1.1%
1.3%
Cash Conversion
ACTG
ACTG
CTKB
CTKB
Q4 25
22.01×
Q3 25
Q2 25
Q1 25
0.10×
Q4 24
0.21×
Q3 24
14.05×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACTG
ACTG

Energy Operations$16.0M32%
Transportation Safety$10.4M21%
Office Storage And Display Solutions$8.4M17%
Printers Consumables And Parts$6.5M13%
Natural Gas Reserves$5.1M10%
Natural Gas Liquids Reserves$3.3M7%

CTKB
CTKB

Products$46.6M75%
Services$15.5M25%

Related Comparisons